Cinctive Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-117,421
| Closed | -$2.59M | – | 439 |
|
|
2024
Q4 | $2.59M | Sell |
117,421
-116,074
| -50% | -$2.56M | 0.13% | 188 |
|
|
2024
Q3 | $4.21M | Buy |
233,495
+71,164
| +44% | +$1.28M | 0.23% | 138 |
|
|
2024
Q2 | $2.64M | Sell |
162,331
-223,877
| -58% | -$3.64M | 0.13% | 201 |
|
|
2024
Q1 | $5.45M | Buy |
386,208
+140,278
| +57% | +$1.98M | 0.25% | 116 |
|
|
2023
Q4 | $2.57M | Buy |
+245,930
| New | +$2.57M | 0.17% | 154 |
|
|
2020
Q3 | – | Sell |
-153,486
| Closed | -$1.89M | – | 362 |
|
|
2020
Q2 | $1.89M | Buy |
153,486
+54,942
| +56% | +$677K | 0.22% | 188 |
|
|
2020
Q1 | $885K | Buy |
+98,544
| New | +$885K | 0.2% | 153 |
|